adMare BioInnovations — 2020 Investments

1 investments dated 2020 · listed companies and verified rows first · show all

Inversagoinversago.comSep 2020 · $35Macquired by Novo Nordisk

Portfolio company acquired by Novo Nordisk for $1.1B USD.

Co-investorsAmorChem Genesys Capital JDRF T1D Fund New Enterprise Associates (NEA)Tarnagulla Ventures Amgen Ventures +2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.